LITS
Lite Strategy, Inc.Healthcare · $47M market cap
Verdict
We can't put a fair value on LITS right now. Its earnings are too small compared with its share price for an earnings-based value to mean anything.
Business quality
1 of 5 clear the 10% bar. What are the Big Five?
Follow LITS
Track it on your watchlist and see the full analysis. Free.
Create a free accountInsider activity
Since Jul 22, 2025: 2 open-market purchases worth $13K and 5 other filings (stock awards, tax withholding and similar). Why purchases matter
Purchases
Other filings
Questions about LITS
Are insiders buying LITS?
Since Jul 22, 2025: 2 open-market purchases worth $13K and 5 other filings (stock awards, tax withholding and similar).
How can I check LITS's value myself?
Use the free Sticker Price calculator, already filled with LITS's numbers. Change the growth, P/E or required return and see what you'd pay. Open the calculator →
Similar stocks · Biotechnology
About Lite Strategy, Inc.
Lite Strategy, Inc. functions as a clinical-stage pharmaceutical firm, concentrating its efforts on creating innovative and distinct therapeutic solutions for cancer patients. This entity, which was previously known as MEI Pharma, Inc., officially changed its designation to Lite Strategy, Inc. in September 2025. The company was established in 2000 and has its principal operations located in San Diego, California.
Biotechnology
Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of Oct 26, 2026. How the Payback Price works